rs199473577
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP2
The NM_001099404.2(SCN5A):c.1858C>T(p.Arg620Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000287 in 1,533,762 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R620H) has been classified as Uncertain significance.
Frequency
Consequence
NM_001099404.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SCN5A | NM_001099404.2 | c.1858C>T | p.Arg620Cys | missense_variant | 12/28 | ENST00000413689.6 | |
SCN5A | NM_000335.5 | c.1858C>T | p.Arg620Cys | missense_variant | 12/28 | ENST00000423572.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SCN5A | ENST00000413689.6 | c.1858C>T | p.Arg620Cys | missense_variant | 12/28 | 5 | NM_001099404.2 | P4 | |
SCN5A | ENST00000423572.7 | c.1858C>T | p.Arg620Cys | missense_variant | 12/28 | 1 | NM_000335.5 | A1 |
Frequencies
GnomAD3 genomes ? AF: 0.0000329 AC: 5AN: 152156Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000313 AC: 6AN: 191644Hom.: 0 AF XY: 0.0000198 AC XY: 2AN XY: 101126
GnomAD4 exome AF: 0.0000282 AC: 39AN: 1381606Hom.: 0 Cov.: 30 AF XY: 0.0000222 AC XY: 15AN XY: 676992
GnomAD4 genome ? AF: 0.0000329 AC: 5AN: 152156Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74326
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Mar 23, 2023 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 620 of the SCN5A protein (p.Arg620Cys). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change affects SCN5A function (PMID: 24573164, 25904541). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 67694). This missense change has been observed in individual(s) with clinical features of SCN5A-related conditions (PMID: 20129283, 24667783, 29728395, 30193851, 32880476). This variant is present in population databases (rs199473577, gnomAD 0.01%). - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jun 08, 2022 | Functional studies demonstrate that co-expression with wild type did not reduce peak current densities (Hoshi et al., 2014); Reported in association with Brugada syndrome, LQTS, and DCM (Kapplinger et al., 2010; Hazebroek et al., 2015; Kapplinger et al., 2015; Kroncke et al., 2018; Berthome et al., 2019; Verdonschot et al., 2020); Identified in a proband and two siblings with LQTS; all three individuals also harbored a pathogenic KCNQ1 variant (Riur et al., 2015); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 30193851, 32880476, 20129283, 24573164, 26383716, 29728395, 30662450, 24667783, 25904541) - |
Cardiac arrhythmia Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Sep 17, 2023 | This missense variant replaces arginine with cysteine at codon 620 of the SCN5A protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). Functional studies have shown that this variant does not cause a reduction in peak current densities when co-expressed with a wild type protein (PMID: 24573164). This variant has been reported in an individual suspected of having Brugada syndrome (PMID: 20129283). This variant has also been observed in three individuals in a family affected with Long QT syndrome (PMID: 24667783). However, all of these individuals carried a pathogenic variant in KCNQ1, suggesting that this SCN5A variant was likely not the primary cause of disease. This variant has been identified in 7/223000 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Sep 07, 2023 | This missense variant replaces arginine with cysteine at codon 620 of the SCN5A protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). Functional studies have shown that this variant does not cause a reduction in peak current densities when co-expressed with a wild type protein (PMID: 24573164). This variant has been reported in an individual suspected of having Brugada syndrome (PMID: 20129283). This variant has also been observed in three individuals in a family affected with Long QT syndrome (PMID: 24667783). However, all of these individuals carried a pathogenic variant in KCNQ1, suggesting that this SCN5A variant was likely not the primary cause of disease. This variant has been identified in 7/223000 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Brugada syndrome Other:1
not provided, no classification provided | literature only | Cardiovascular Biomedical Research Unit, Royal Brompton & Harefield NHS Foundation Trust | - | This variant has been reported as associated with Brugada syndrome in the following publications (PMID:20129283). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at